Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients (Q42200492)

18 October 2017

title

Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients (English)

1 reference

18 October 2017

1 reference

3

Arnold S Monto

1 reference

18 October 2017

1

Menno D de Jong

1 reference

18 October 2017

Michael G Ison

2

1 reference

18 October 2017

Hristo Metev

4

1 reference

18 October 2017

Carol Clark

5

1 reference

18 October 2017

Brian O'Neil

6

1 reference

18 October 2017

Jenna Elder

7

1 reference

18 October 2017

Amy McCullough

8

1 reference

18 October 2017

Phil Collis

9

1 reference

18 October 2017

William P Sheridan

10

1 reference

18 October 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

Clinical Infectious Diseases

18 October 2017

published in

1 reference

18 October 2017

volume

59

1 reference

18 October 2017

issue

12

1 reference

18 October 2017

page(s)

e172-85

1 reference

Influenza-associated hospitalizations in the United States

18 October 2017

cites work

1 reference

Estimates of US influenza-associated deaths made using four different methods

21 January 2018

1 reference

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010)

21 January 2018

1 reference

Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment

21 January 2018

1 reference

Epidemiology of human infections with avian influenza A(H7N9) virus in China.

21 January 2018

1 reference

Clinical findings in 111 cases of influenza A (H7N9) virus infection

21 January 2018

1 reference

Pandemic influenza viruses--hoping for the road not taken

21 January 2018

1 reference

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

21 January 2018

1 reference

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

21 January 2018

1 reference

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

21 January 2018

1 reference

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease

21 January 2018

1 reference

Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors

21 January 2018

1 reference

Drugs in development for influenza

21 January 2018

1 reference

Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro

21 January 2018

1 reference

Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection

21 January 2018

1 reference

Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection

21 January 2018

1 reference

Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients

21 January 2018

1 reference

Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus Infection

21 January 2018

1 reference

The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza

21 January 2018

1 reference

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus

21 January 2018

1 reference

Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States

21 January 2018

1 reference

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

21 January 2018

1 reference

Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy

21 January 2018

1 reference

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

21 January 2018

1 reference

Sample-size formula for the proportional-hazards regression model

21 January 2018

1 reference

Type I error in sample size re-estimations based on observed treatment difference

21 January 2018

1 reference

Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1093/CID/CIU632

1 reference

18 October 2017

1 reference